We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

I’d invest £4,200 in this FTSE 250 REIT for £350 in passive income a year

This FTSE 250 REIT offers a massive dividend yield. Our writer outlines how he’d invest in its shares to supplement his income in 2023.

| More on:
Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Target Healthcare REIT (LSE: THRL) is one of the top five yielding shares in the FTSE 250 index. The property company operates in the healthcare sector, counting a large number of care homes in its real estate portfolio.

The real estate investment trust (REIT) offers an 8.38% annual dividend yield. This is considerably above the average yields for both the FTSE 100 and FTSE 250.

Should you buy Target Healthcare REIT Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

If I had spare cash to invest, here’s how I’d target £350 in annual passive income by investing in the company.

Dividend income from property

Investing in REITs is a great way to diversify my stock market portfolio. They offer exposure to income-producing real estate in a passive way, allowing me to avoid the headaches that can come from being a landlord.

Target Healthcare is one of the highest yielding REITs in the UK market, so I think it merits serious consideration for my portfolio.

Following a big fall in recent months, the Target Healthcare share price stands at 80.50p as I write. Big share price volatility can create value investment opportunities, and I think this REIT falls into that category. If I had £4,200 to invest in the FTSE 250 stock today, I could buy 5,217 shares.

The share price decline has pushed the dividend yield up. Accordingly, if I invested now, I’d earn a little under £352 in passive income just from holding the shares for a year.

As a long-term investor, I’d be inclined to hold the shares for longer than 12 months. If I reinvested my dividends into more shares, I could begin to benefit from a compounding effect on my investments.

The outlook for Target Healthcare REIT

One reason I’m bullish on Target Healthcare is the demographic transformation underway in the UK. According to the ONS, the number of UK residents aged 65 or older will reach 20.4m by 2066, equating to 26% of the total population. An aging population means increased demand for care provision.

I also like the stock’s defensive qualities. Its lease structures are long term (typically 30-35 years) and inflation linked. It’s also non-cyclical, as demand for social care isn’t dependent on the performance of the wider economy.

In addition, the properties in the group’s portfolio are modern and purpose-built. Medical issues such as incontinence make the provision of en-suite wet rooms an important consideration. Around 96% of the group’s homes have wet rooms, compared to a 29% national comparative.

Target Healthcare also continues to make progress with regards to occupancy rates. After a reduction during the Omicron wave during the pandemic, occupancy levels have climbed since March 2022, according to the company’s latest data. High occupancy is essential for the group’s rental income.

Source: Target Healthcare REIT Annual Report 2022

There are some risks facing the REIT. Dividend cover is a concern at 72%. If the company’s profitability came under pressure, I’m worried the jumbo dividend yield might not be sustainable.

High inflation is another challenge facing the business. Increased costs for staff, building materials, and energy could erode the company’s margins.

Nonetheless, overall I think long-term tailwinds will boost the share price performance. With some spare cash, I’d invest in the REIT to target a regular passive income stream today.

Charlie Carman has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

At 8.1%, are investors missing the bigger story behind Legal & General shares?

Andrew Mackie explores Legal & General shares and asks whether investors are still viewing it too narrowly as a yield…

Read more »

Young black female footballer training on stadium pitch
Investing Articles

How has this FTSE 250 share surged ANOTHER 7% today?

Applied Nutrition shares have soared on Monday after another brilliant trading update. So what's the FTSE 250 company's secret?

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

The stock market game you’re actually playing (and why you might be losing)

Our writer recounts a painful experience of making a rash stock market decision based on emotions, not logic – and…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Why is EasyJet stock suddenly a takeover target for US investors?

Andrew Mackie looks at easyjet shares jumping on US takeover talk — but is this a genuine re-rating or just…

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

Have investors got BT shares all wrong?

BT shares spiked during the 1990s telecom boom, then struggled for two decades. Harvey Jones says it's the future that…

Read more »

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

Looking for buying opportunities in June? Here’s 1 to consider from my Stocks and Shares ISA

The conflict in Iran is making one of the investments in Stephen Wright’s Stocks and Shares ISA volatile. But could…

Read more »

Row of blue European Union flags in Brussels.
Investing Articles

After crashing 13.7% today, is Wise now a stock market bargain at 805p?

Wise was one of the biggest fallers on the UK stock market today. What on earth is going on with…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

At 8% is this eye-popping FTSE 100 dividend yield simply too good to be true?

The dividend yield is to die for, but the share price is lacking in life. Harvey Jones examines whether this…

Read more »